Topic: Science - Medicine

In a groundbre end-of-year update on healthcare technology developments in Boston this December, Dr. Emily Chen leads an international team of researchers who have created the most advanced biochip yet—a device that can predict with near certainty whether individuals are at risk for several genetic diseases before they even manifest symptoms. "We're talking about potentially a paradigm shift in preventive healthcare," says Dr. Chen, CEO of GenoTech Labs during an interview on Monday morning.

Chen’s biochip uses AI to analyze data from thousands of genetic markers simultaneously and identifies subtle mutations associated with serious conditions like Alzheimer's disease, muscular dystrophy, and various cancers earlier than any test available today. "It could change everything for families who carry these diseases," explains Dr. Benjamin Clarke, head researcher at the Massachusetts Institute of Medicine (MIT).

The team worked closely with a consortium of technology companies to develop this non-invasive chip that requires just saliva samples and sends results back in real time via cloud computing services. In testing phases across Boston hospitals during November 20XX, Chen's biochip was able to identify genetic risks for diseases with over an astounding accuracy rate of 95%.

"If we can catch these things early on and intervene accordingly," says Clarke in a follow-up statement released yesterday, "we could potentially halt or even reverse the progression of some conditions." MIT confirms plans to expand trials nationally next year. Chen's biochip is already generating international interest as doctors around the world seek tools for better patient care.

CNN Health and DailyMail Science Correspondents.